Galera Therapeutics(GRTX)

chuminhua2023-08-10 13:21

8/9，FDA 周三向 Galera Therapeutics $Galera Therapeutics(GRTX)$ 发出了一份完整回复应信 (CRL)，内容涉及 Galera Therapeutics 的 avasopasem 用于治疗接受标准护理的头颈癌 (HNC) 患者因放疗引起的严重口腔粘膜炎 (SOM) 治疗的上市申请。 因此，Galera 表示将裁员 70%，作为增加现金流的更广...查看全文

Kate7311172023-08-10 05:04

$Galera Therapeutics(GRTX)$ 爽赌小药的那种感觉又回来了查看全文

牛唐2023-04-03 22:38

$Galera Therapeutics(GRTX)$ 又一个近70%的收益。$阿里巴巴(BABA)$ $理想汽车(LI)$查看全文

产业链观察2023-02-15 21:26

#药闻简讯# $Galera Therapeutics(GRTX)$ 宣布FDA接受并优先审查Avasopasem NDA用于放疗诱发的严重口腔粘膜炎。
PDUFA 08/09/23查看全文

超过5%股东持股披露

Galera Therapeutics(GRTX)04-17 04:45

$Galera Therapeutics(GRTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001376474-24-000167  Act: 34  Size: 29 KB 网页链接查看全文

持股变动年度报告

Galera Therapeutics(GRTX)04-02 09:45

$Galera Therapeutics(GRTX)$ 5 Annual statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002047  Size: 15 KB 网页链接查看全文

年度财报

Galera Therapeutics(GRTX)03-28 19:35

$Galera Therapeutics(GRTX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-037614  Act: 34  Size: 9 MB 网页链接查看全文

当期报告

Galera Therapeutics(GRTX)03-28 19:15

$Galera Therapeutics(GRTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-079600  Act: 34  Size: 213 KB 网页链接查看全文

超过5%股东持股披露「修订」

Galera Therapeutics(GRTX)04-03 20:15

$Galera Therapeutics(GRTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001683168-24-002071  Act: 34  Size: 45 KB 网页链接查看全文

当期报告

Galera Therapeutics(GRTX)03-27 19:35

$Galera Therapeutics(GRTX)$ 8-K Current report, item 3.01 Accession Number: 0001193125-24-078226  Act: 34  Size: 151 KB 网页链接查看全文

超过5%股东持股披露

$Galera Therapeutics(GRTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001376474-24-000167  Act: 34  Size: 29 KB 网页链接

超过5%股东持股披露「修订」

$Galera Therapeutics(GRTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001683168-24-002071  Act: 34  Size: 45 KB 网页链接

持股变动年度报告

$Galera Therapeutics(GRTX)$ 5 Annual statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002047  Size: 15 KB 网页链接

年度财报

$Galera Therapeutics(GRTX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-037614  Act: 34  Size: 9 MB 网页链接

当期报告

$Galera Therapeutics(GRTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-079600  Act: 34  Size: 213 KB 网页链接

当期报告

$Galera Therapeutics(GRTX)$ 8-K Current report, item 3.01 Accession Number: 0001193125-24-078226  Act: 34  Size: 151 KB 网页链接

持股变动声明

$Galera Therapeutics(GRTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-016923  Size: 13 KB 网页链接

超过5%股东持股披露「修订」

$Galera Therapeutics(GRTX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-025667  Act: 34  Size: 95 KB 网页链接

超过5%股东持股披露「修订」

$Galera Therapeutics(GRTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023133  Act: 34  Size: 72 KB 网页链接

超过5%股东持股披露

$Galera Therapeutics(GRTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-003834  Act: 34  Size: 32 KB 网页链接